MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Pursuant to regulation 30 of SEBI (LODR), kindly note that the members of the Company at the AGM held on Monday August 28, 2023 have inter alia approved the amendment to the Articles of Association of the Company. MARKSANS PHARMA LTD. - 524404 - Voting Results Along With Scrutinizers Report
Pursuant to Regulation 44(3) of LODR, Results of the voting through remote evoting and evoting during AGM held on 28th August, 2023 through video conferencing along with consolidated Scrutinizers Reports. MARKSANS PHARMA LTD. - 524404 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to regulation 30 of SEBI (LODR) regulations, 2015, kindly find enclosed herewith proceedings of 31st AGM of Marksans Pharma Limited MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
This is to inform you that the officials of the Company will be participating in the investor/analyst conference on August 28, 2023. MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
In terms of company''s code of conduct read with schedule B & regulation 9 of SEBI (PIT) regulations, we hereby submit a report in respect of violation of insider trading code of the Company as per the format prescribed by SEBI. MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Kindly find enclosed herewith copy of Press release of the Company for receipt of USFDA approval for Guaifenesin extended release tablets (OTC) MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to regulation 30 read with para A of schedule III of SEBI (LODR) Regulations, 2015, kindly find enclosed the transcript of the investors / analysts meet for Q1FY2024. The information is also available on the website of the Company. MARKSANS PHARMA LTD. - 524404 - Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations
Pursuant to regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, kindly find enclosed form C. MARKSANS PHARMA LTD. - 524404 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have received one request for issue of duplicate share certificate on August 17, 2023 MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the aforesaid Financial Results Conference Call is hosted on the website of the Company under the following link: http://marksanspharma.com/investors-meet.html